Abeona Therapeutics (ABEO) AGM 2026 summary

Opening remarks and agenda

• Meeting opened with acknowledgment of Michael Amoroso's resignation from the board for personal reasons, not related to company matters.

• Michael Amoroso's name withdrawn from board election; no replacement nominated.

• Principal agenda items included director elections, executive compensation, auditor ratification, equity plan amendment, and certificate of incorporation amendment.

Board and executive committee updates

• Michael Amoroso thanked for years of service; his resignation effective prior to the meeting.

• No replacement director nominated for election at this meeting.

Shareholder proposals

• Election of two Class I Directors for three-year terms.

• Advisory approval of executive compensation.

• Ratification of Deloitte & Touche LLP as independent auditor for 2026.

• Approval sought to increase shares reserved under the 2023 Equity Incentive Plan from $8.4M to $11.5M.

• Proposal to amend certificate of incorporation to remove advance notice provision for director nominations.